Florian Lagler

Florian Lagler is a Professor and Head of the University Clinic for Pediatrics and Adolescent Medicine as well as the University Institute for Inborn Metabolic Diseases at Paracelsus Medical University. His research focuses on rare genetic disorders such as mucopolysaccharidoses, mannosidosis, and phenylketonuria, with an emphasis on clinical management, care coordination, and innovative treatment strategies. He leads multiple research projects, including studies on enzyme replacement therapies and anesthesia safety in rare disease patients. Lagler has organized numerous international conferences and workshops, demonstrating his role in advancing pediatric and metabolic medicine globally.

Key research areas include personalized medicine for rare diseases, development of diagnostic tools, and optimizing patient care through multidisciplinary approaches. His work spans over 131 publications since 2009, with a focus on clinical trials, consensus guidelines, and retrospective cohort studies. Lagler has also contributed to projects like the 'Development of a specific airway-trainer for MPS patients' and 'Enzyme-Replacement Therapy Home Therapy Impact Study.'

He actively participates in academic leadership, having coordinated initiatives such as the 7th European Symposium on Lysosomal Storage Diseases and the OKIDS EUPATI Congress. His efforts bridge clinical practice and translational research, addressing unmet needs in treating metabolic and rare pediatric conditions.